Addex Therapeutics Stock Analysis

ADXN Stock  USD 25.30  0.27  1.06%   
Addex Therapeutics is overvalued with Real Value of 20.36 and Hype Value of 25.19. The main objective of Addex Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Addex Therapeutics is worth, separate from its market price. There are two main types of Addex Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Addex Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Addex Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Addex Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Addex Therapeutics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Addex Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Addex Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.

Addex Stock Analysis Notes

About 18.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 19.71. Addex Therapeutics had not issued any dividends in recent years. The entity had 1:20 split on the 23rd of October 2023. Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system disorders in Switzerland. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland. Addex Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people. For more info on Addex Therapeutics please contact Timothy Dyer at 41 22 884 1555 or go to https://www.addextherapeutics.com.

Addex Therapeutics Quarterly Total Revenue

327,733

Addex Therapeutics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Addex Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Addex Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Addex Therapeutics is way too risky over 90 days horizon
Addex Therapeutics appears to be risky and price may revert if volatility continues
Addex Therapeutics has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 2.05 M. Net Loss for the year was (11.35 M) with profit before overhead, payroll, taxes, and interest of 1.44 M.
Addex Therapeutics currently holds about 8.81 M in cash with (10.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.4.
Latest headline from news.google.com: Addex Therapeutics Ltd Short Interest Update - Defense World

Addex Therapeutics Upcoming and Recent Events

Earnings reports are used by Addex Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Addex Therapeutics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of April 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Addex Largest EPS Surprises

Earnings surprises can significantly impact Addex Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-11-04
2021-09-30-0.8527-0.7230.129715 
2021-05-05
2021-03-31-0.6565-0.52560.130919 
2021-08-05
2021-06-30-0.7876-0.9263-0.138717 
View All Earnings Estimates

Addex Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Addex Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Addex Therapeutics backward and forwards among themselves. Addex Therapeutics' institutional investor refers to the entity that pools money to purchase Addex Therapeutics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
J Stern & Co Llp2023-12-31
107.8 K
Armistice Capital, Llc2023-12-31
43 K
Nea Management Company, Llc2023-12-31
K
Note, although Addex Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Addex Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 27.09 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Addex Therapeutics's market, we take the total number of its shares issued and multiply it by Addex Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Addex Profitablity

Addex Therapeutics' profitability indicators refer to fundamental financial ratios that showcase Addex Therapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, Addex Therapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Addex Therapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Addex Therapeutics' profitability requires more research than a typical breakdown of Addex Therapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.89)(2.74)
Return On Capital Employed(4.72)(4.48)
Return On Assets(2.89)(2.74)
Return On Equity(4.87)(4.63)

Management Efficiency

Addex Therapeutics has return on total asset (ROA) of (0.7547) % which means that it has lost $0.7547 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.9083) %, meaning that it created substantial loss on money invested by shareholders. Addex Therapeutics' management efficiency ratios could be used to measure how well Addex Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 15th of April 2024, Return On Tangible Assets is likely to grow to -2.74. In addition to that, Return On Capital Employed is likely to grow to -4.48. At this time, Addex Therapeutics' Other Current Assets are very stable compared to the past year. As of the 15th of April 2024, Intangible Assets is likely to grow to about 30.8 M, while Total Assets are likely to drop about 7.1 M.
Last ReportedProjected for Next Year
Book Value Per Share 0.13  0.12 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 0.13  0.12 
Enterprise Value Over EBITDA(29.63)(31.11)
Price Book Value Ratio 96.40  89.60 
Enterprise Value Multiple(29.63)(31.11)
Price Fair Value 96.40  89.60 
Enterprise Value467.7 M554.8 M
The analysis of Addex Therapeutics' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Addex Therapeutics' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Addex Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.759

Technical Drivers

As of the 15th of April 2024, Addex Therapeutics shows the mean deviation of 5.65, and Risk Adjusted Performance of 0.1648. Addex Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated nineteen technical drivers for Addex Therapeutics, which can be compared to its peers. Please confirm Addex Therapeutics standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if Addex Therapeutics is priced correctly, providing market reflects its regular price of 25.3 per share. Given that Addex Therapeutics has jensen alpha of 1.99, we suggest you to validate Addex Therapeutics's prevailing market performance to make sure the company can sustain itself at a future point.

Addex Therapeutics Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Addex Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Addex Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Addex Therapeutics Predictive Daily Indicators

Addex Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Addex Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Addex Therapeutics Corporate Filings

6K
3rd of April 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
30th of January 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
21st of December 2023
Other Reports
ViewVerify
6K
20th of December 2023
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
14th of December 2023
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
F3
8th of December 2023
An amendment to the original Schedule 13D filing
ViewVerify
30th of November 2023
Other Reports
ViewVerify
6K
29th of November 2023
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify

Addex Therapeutics Forecast Models

Addex Therapeutics' time-series forecasting models are one of many Addex Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Addex Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Addex Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Addex Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Addex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Addex Therapeutics. By using and applying Addex Stock analysis, traders can create a robust methodology for identifying Addex entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(13.16)(13.82)
Operating Profit Margin(12.98)(13.63)
Net Loss(13.16)(13.82)
Gross Profit Margin(10.67)(10.14)

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Addex Therapeutics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module
When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Addex Stock analysis

When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(19.71)
Revenue Per Share
3.72
Quarterly Revenue Growth
(0.21)
Return On Assets
(0.75)
Return On Equity
(1.91)
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.